Earnings Call · Q4 FY2025·2026-03-04

Q4 25EPS +56.73%·Rev n/aQ3 25EPS +44.27%·Rev n/aQ2 25EPS +8.38%·Rev n/aQ1 25EPS +14.29%·Rev n/a⚠ consensus missing

Cellectar Biosciences, Inc. CLRB

Anne Marie Fields — Investor Relations

Jim Caruso — President and CEO

Chad Kolean — Chief Financial Officer

Jarrod Longcor — Chief Medical Officer

+8.2%1d on move date+7.5% vs SPY3d+3.0%5d+13.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CLRB calls or request research access.

More CLRB calls Browse calls Request research access